In a longitudinal study, PD patients were followed for up to 20 years after initial presentations and plasma total α-synuclein and phosphorylated α-synuclein or pS129 were measured repeatedly (Foulds et al., 2013). The gene discussed is SNCA; the disease is Parkinson disease.